March 24, 2025

Tildrakizumab Shows Lasting Efficacy in Scalp Psoriasis

Tildrakizumab may provide durable response for scalp psoriasis, a phase 3b study found, confirming sustained efficacy and safety through 52 weeks.

Conexiant

March 21, 2025

Biosimilars Match Adalimumab Originator Efficacy for Psoriasis

Amjevita and Imraldi were as effective as Humira for both new starters and patients switching from Humira, researchers concluded

Conexiant

March 19, 2025

Study: Sex Differences in Physician Suicide

Researchers found that female physicians had a significantly higher suicide risk than female nonphysicians.

Conexiant

March 18, 2025

Effective Strategies for Dermatology Conference Presentations

The researchers discuss techniques and routines to help presenters manage prepresentation anxiety.

Conexiant

March 14, 2025

Effective Strategies for Dermatology Conference Presentations

The researchers discuss techniques and routines to help presenters manage prepresentation anxiety.

Conexiant

March 11, 2025

Doctors Never Truly Vacation, Study Reveals

"Organizations should implement strategies to minimize clinical tasks during PTO."

Conexiant

March 06, 2025

COVID-19 Increases Autoimmune Blistering Disease Risk, Study Finds

COVID-19 infection significantly increases autoimmune blistering disease risk, while vaccination appears protective, researchers report in a study analyzing 112 million patient records

Conexiant

March 06, 2025

An Estimated 31 Million Americans Borrowed for Medical Bills in 2024

A new West Health-Gallup Survey survey reveals insights into medical debt across all income levels and demographics in the United States.

Conexiant

March 04, 2025

FDA Approves Prefilled Syringe for Cortrophin Gel

FDA approves a prefilled syringe format for Purified Cortrophin Gel, reducing administration steps for patients with inflammatory and autoimmune conditions.

Conexiant